chlorpromazine has been researched along with carbamazepine in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (39.24) | 18.7374 |
1990's | 7 (8.86) | 18.2507 |
2000's | 20 (25.32) | 29.6817 |
2010's | 20 (25.32) | 24.3611 |
2020's | 1 (1.27) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Hino, K; Karasawa, T; Masuda, Y; Nagai, Y; Oka, M; Uno, H | 1 |
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Elshorst, B; Fiebig, K; Griesinger, C; Grimme, S; Jacobs, DM; Vogtherr, M; Zahn, R | 1 |
Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Sen, S; Sinha, N | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Steele, DE | 1 |
Hazama, H; Inanaga, K; Mori, A; Okuma, T; Otsuki, S; Sarai, K; Takahashi, R; Watanabe, M | 1 |
Vol'f, MSh | 1 |
Oettinger, L | 1 |
Fletcher, HP; Schnell, RC; Wannarka, GL | 1 |
Wada, JA | 1 |
Kinawi, A; Teller, C | 1 |
Kinawi, A; Min, K | 1 |
Aznar Reig, A; Bolaños Díaz, A; De la Vega Vázquez, JM; Fajardo Gálvez, J; Holgado Silva, C | 1 |
Dolan, JD; Kamil, R | 1 |
Borchert, HH; Göckeritz, W | 1 |
Brown, D; Cookson, J; Silverstone, T | 1 |
Samanin, R; Tullii, M; Vezzani, A; Wu, HQ | 1 |
Grossi, E; Lazzerini, F; Lenzi, A; Massimetti, G; Placidi, GF | 1 |
Lippmann, S; Pary, R; Tobias, CR; Turns, DM | 1 |
Kutt, H; Penry, JK | 1 |
Mullan, S | 1 |
Lalla, M; Virolainen, M | 1 |
Wieck, HH | 1 |
Gazengel, J; Lhermitte, F; Marteau, R; Peterfalvi, M; Serdaru, M | 1 |
Trautmann, A | 1 |
Post, RM | 1 |
Hertrich, O | 1 |
Okuma, T | 2 |
Singh, NN; Winton, AS | 1 |
Hershkowitz, N; Mahany, TM; Raines, A | 1 |
Aun, R; de Almeida, GM; de Oliveira Júnior, JO; Segushi, HH; Teixeira, MJ | 1 |
Greim, H | 1 |
Post, RM; Silberman, EK | 1 |
Hellawell, DJ; Wright, S; Young, AW | 1 |
Dehpour, AR; Farahani, M; Farsam, H; Sadeghipour-Roudsari, HR; Shokrgozar, AA | 1 |
Dromerick, AW; Kumar, A | 1 |
Alexishvili, MM; Makharadze, TG; Okujava, VM; Rukhadze, MD; Sebiskveradze, MV; Tsagareli, SK | 1 |
Hardy-Baylé, MC | 1 |
Aina, OF; Morakinyo, O | 1 |
Kanba, S; Miyaoka, H; Nakaki, T; Shintani, F; Suzuki, E | 1 |
Girimaji, SC; Jairam, R; Seshadri, SP; Srinath, S | 1 |
Dzidziguri, DV; Giorgobiani, NM; Kerkenjia, SM; Rukhadze, MD | 1 |
Halwachs, S; Honscha, W; Kneuer, C | 1 |
Brodaty, H; Cumming, R; Forrester, L; Grayson, D; Hollis, J; Touyz, S | 2 |
Ahn, YM; Bae, HJ; Eun, JW; Jin, CY; Kang, HJ; Kim, H; Kim, HS; Lee, JY; Nam, SW; Park, SJ; Park, WS; Shen, Q; Shin, WC; Yang, HD; You, JS | 1 |
Calimli, MH; Kanberoğlu, GS; Karaman, M; Türkan, F | 1 |
7 review(s) available for chlorpromazine and carbamazepine
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pediatric psychopharmacology. A review with special reference to deanol.
Topics: Adolescent; Adult; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child, Preschool; Chlorpromazine; Deanol; Epilepsy; Ethanolamines; Heart Rate; Humans; Learning; Methylphenidate; Pemoline; Phenytoin; Rats; Syndrome; Thioridazine | 1977 |
Pharmacological prophylaxis in the kindling model of epilepsy.
Topics: Amygdala; Anesthetics, Local; Animals; Antidepressive Agents, Tricyclic; Atropine; Aziridines; Carbamazepine; Catecholamines; Cats; Cerebral Cortex; Chlorpromazine; Clorazepate Dipotassium; Diazepam; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Haplorhini; Hydroxydopamines; Phenobarbital; Phenytoin; Rats; Reserpine; Seizures; Valproic Acid | 1977 |
Usefulness of blood levels of antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Chloramphenicol; Chlordiazepoxide; Chlorpromazine; Chromatography, Gas; Dextropropoxyphene; Diazepam; Dicumarol; Disulfiram; Drug Interactions; Epilepsy; Ethosuximide; Humans; Isoniazid; Methylphenidate; Phenethylamines; Phenobarbital; Phenylbutazone; Phenytoin; Primidone; Prochlorperazine; Sulfamethizole; Sulfaphenazole; Thiazines | 1974 |
Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.
Topics: Affective Disorders, Psychotic; Animals; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; gamma-Aminobutyric Acid; Humans; Lithium; Lithium Carbonate; Psychotic Disorders; Psychotropic Drugs | 1982 |
[Enzyme induction in the liver changes drug activity].
Topics: Animals; Barbiturates; Carbamazepine; Chlorpromazine; Drug Interactions; Enzyme Induction; Glutethimide; Humans; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Rifampin; Time Factors | 1980 |
6 trial(s) available for chlorpromazine and carbamazepine
Article | Year |
---|---|
Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Time Factors | 1979 |
Carbamazepine compared to haloperidol in acute mania.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlorpromazine; Female; Haloperidol; Humans; Leukocyte Count; Male; Middle Aged; Procyclidine; Psychiatric Status Rating Scales | 1989 |
Use of carbamazepine in acute psychosis: a controlled study.
Topics: Acute Disease; Adult; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Lithium Carbonate; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Random Allocation | 1986 |
Use of the anticonvulsant carbamazepine in primary and secondary affective illness: clinical and theoretical implications.
Topics: Affective Disorders, Psychotic; Animals; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; gamma-Aminobutyric Acid; Humans; Lithium; Lithium Carbonate; Psychotic Disorders; Psychotropic Drugs | 1982 |
Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Male; Middle Aged | 1983 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Imipramine; Lithium Carbonate; Male; Phenotype; Prospective Studies; Recovery of Function; Risperidone; Secondary Prevention; Severity of Illness Index; Valproic Acid | 2004 |
67 other study(ies) available for chlorpromazine and carbamazepine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
A novel class of potential central nervous system agents. 3-Phenyl-2-(1-piperazinyl)-5H-1-benzazepines.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Body Temperature Regulation; Brain; Electroshock; Exploratory Behavior; Homovanillic Acid; Hypothermia; Indicators and Reagents; Male; Mice; Mice, Inbred Strains; Piperazines; Rats; Rats, Inbred Strains; Reserpine; Seizures; Structure-Activity Relationship | 1988 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein.
Topics: Antimalarials; Binding Sites; Chloroquine; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Peptide Fragments; Phenothiazines; Prions; Protein Structure, Secondary; Quinacrine; Recombinant Proteins; Structure-Activity Relationship | 2003 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Tic doloureux.
Topics: Carbamazepine; Chlorpromazine; Humans; Male; Phenytoin; Trigeminal Neuralgia | 1975 |
[Psychotropic drugs in the clinical picture of epilepsy (review of the literature)].
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Chlordiazepoxide; Chlorpromazine; Drug Synergism; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Glycerol; Humans; Methotrimeprazine; Mice; Pentylenetetrazole; Phenothiazines; Promethazine; Psychotic Disorders; Seizures; Thioridazine | 1975 |
Variations of chlorpromazine-related isosteres on the glycemic response in mice.
Topics: Adrenalectomy; Animals; Blood Glucose; Carbamazepine; Chlorpromazine; Clomipramine; Cyproheptadine; Hyperglycemia; Imipramine; Insulin; Islets of Langerhans; Male; Mice; Promazine | 1979 |
[Determination of drug-albumin binding in buffered bovine serum albumin solutions applying a modified ultrafiltration process (author's transl)].
Topics: Animals; Carbamazepine; Cattle; Chlorpromazine; Methods; Pharmaceutical Preparations; Phenobarbital; Phenprocoumon; Protein Binding; Serum Albumin, Bovine; Ultrafiltration | 1979 |
[Application of hplc-techniques to gel filtration in the determination of drug albumin binding (author's transl)].
Topics: Animals; Carbamazepine; Cattle; Chlorpromazine; Chromatography, Gel; Chromatography, High Pressure Liquid; Phenobarbital; Protein Binding; Serum Albumin, Bovine | 1978 |
[Diabetes insipidus. Clinico-pharmalogical correlations and their therapeutic results with various substances].
Topics: Carbamazepine; Chlorpromazine; Clofibrate; Diabetes Insipidus; Diuresis; Drug Evaluation; Drug Therapy, Combination; Humans; Osmolar Concentration; Vasopressins | 1978 |
Atypical affective disorder with episodic dyscontrol: a case of von Economo's disease (encephalitis lethargica).
Topics: Adult; Antipsychotic Agents; Carbamazepine; Chlorpromazine; Chronic Disease; Electroencephalography; Encephalitis, Arbovirus; Follow-Up Studies; Humans; Lorazepam; Male; Mood Disorders; Sexual Behavior | 1992 |
[The effect of chlorpromazine and carbamazepine on diagnostically relevant liver enzymes].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbamazepine; Chlorpromazine; Glutamate Dehydrogenase; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Male; Rats; Rats, Inbred Strains | 1990 |
Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
Topics: Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Chlorpromazine; Diazepam; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Male; Phenobarbital; Phenytoin; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Seizures; Valproic Acid | 1986 |
[Drug selection after overdose recovery: carbamazepine or lithium].
Topics: Adult; Carbamazepine; Chlorpromazine; Humans; Lithium; Male; Risk; Suicide Prevention | 1987 |
Surgical management of pain in cancer of the head and neck.
Topics: Alcohols; Autonomic Nerve Block; Carbamazepine; Chlorpromazine; Cranial Nerves; Gastrostomy; Head; Head and Neck Neoplasms; Humans; Medulla Oblongata; Methadone; Neck; Neoplasms; Pain; Sensation; Spinal Cord; Spinal Fusion; Tracheotomy; Trigeminal Nerve | 1973 |
Blood lymphoblast proliferation in vivo in cutaneous drug hypersensitivity reactions.
Topics: Blood Cell Count; Carbamazepine; Chlorpromazine; Drug Hypersensitivity; Exanthema; Humans; Lymphocytes; Nitrofurantoin; Phenytoin; Prednisone; Stevens-Johnson Syndrome; Sulfonamides; Thymidine; Trimethoprim; Tritium; Urticaria | 1974 |
[Headache. Diagnosis and therapy in general practice].
Topics: Carbamazepine; Chlorpromazine; Depression; Ergotamine; Giant Cell Arteritis; Headache; Humans; Migraine Disorders; Neuralgia; Promethazine; Trigeminal Neuralgia | 1974 |
[Pharmacological analysis of a case of postanoxic intention and action myoclonus].
Topics: 5-Hydroxytryptophan; Alcohols; Anticonvulsants; Benzoates; Carbamazepine; Chlorpromazine; Diazepam; Dibenzazepines; Dopamine; Ergotamine; Female; Haloperidol; Humans; Hypoxia, Brain; Methotrimeprazine; Methyldopa; Methysergide; Middle Aged; Myoclonus; Norepinephrine; Phenobarbital; Pyrrolidines; Stereotaxic Techniques; Sulfonamides; Tranquilizing Agents; Trihexyphenidyl | 1971 |
[Dialysis of drugs and poisons. 2].
Topics: Acetaminophen; Aminopyrine; Amitriptyline; Aspirin; Carbamazepine; Chlordiazepoxide; Chlorpromazine; Dextropropoxyphene; Diazepam; Heroin; Humans; Imipramine; Lithium; Pargyline; Pentazocine; Phenacetin; Phenelzine; Phenytoin; Poisoning; Primidone; Promazine; Renal Dialysis; Salicylates; Tranylcypromine; Trifluoperazine | 1972 |
[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 2].
Topics: Bromazepam; Carbamazepine; Chlordiazepoxide; Chlorpromazine; Humans; Perphenazine; Psychophysiologic Disorders; Psychotic Disorders; Schizophrenia; Temazepam; Tranquilizing Agents | 1983 |
Behavioral monitoring of pharmacological interventions for self-injury.
Topics: Adolescent; Behavior; Behavior Therapy; Carbamazepine; Chlorpromazine; Circadian Rhythm; Humans; Intellectual Disability; Male; Overlearning; Self Mutilation; Thioridazine | 1984 |
Effects of carbamazepine on muscle tone in the decerebrate cat.
Topics: Animals; Carbamazepine; Cats; Chlorpromazine; Decerebrate State; Electric Stimulation; Female; Male; Motor Neurons; Muscle Contraction; Muscle Relaxation | 1983 |
[Genitofemoral neuralgia].
Topics: Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Chlorpromazine; Female; Humans; Lumbosacral Plexus; Male; Middle Aged; Neuralgia | 1982 |
Differential sensitivity to the effects of psychotropic drugs: psychotics vs normals; Asian vs Western populations.
Topics: Bipolar Disorder; Carbamazepine; Chlorpromazine; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Drug Tolerance; Electroencephalography; Humans; Imipramine; Japan; Psychotropic Drugs; Schizophrenia | 1981 |
The march of symptoms in a psychotic decompensation. Case report and theoretical implications.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Behavior; Carbamazepine; Chlorpromazine; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Female; Humans; Psychotic Disorders; Schizophrenia | 1980 |
Sequential Cotard and Capgras delusions.
Topics: Adult; Brain; Capgras Syndrome; Carbamazepine; Chlorpromazine; Delusions; Depressive Disorder; Electroencephalography; Humans; Male; Memory Disorders; Perphenazine; Psychiatric Status Rating Scales | 1993 |
Decrease in erythrocyte:plasma lithium ratio by concurrent administration of psychotropic drugs and lithium in mice.
Topics: Animals; Antipsychotic Agents; Carbamazepine; Chlorpromazine; Drug Therapy, Combination; Erythrocytes; Haloperidol; Imipramine; Lithium; Male; Mice; Prospective Studies | 1998 |
Intractable hiccups during stroke rehabilitation.
Topics: Aged; Baclofen; Carbamazepine; Cerebral Infarction; Cerebrovascular Disorders; Chlorpromazine; Dopamine Antagonists; Haloperidol; Hiccup; Humans; Incidence; Male; Middle Aged; Muscle Relaxants, Central; Pons; Retrospective Studies | 1998 |
Interaction of carbamazepine and chlorpromazine in rabbits.
Topics: Animals; Anticonvulsants; Carbamazepine; Chlorpromazine; Chromatography, High Pressure Liquid; Drug Interactions; Rabbits | 1999 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnosis, Differential; Haloperidol; Hospitalization; Humans; Iatrogenic Disease; Lithium; Neurocognitive Disorders; Schizophrenia; Syndrome; Time Factors; Valproic Acid | 1998 |
Landau-Kleffner syndrome (acquired epileptic aphasia) in a Nigerian child.
Topics: Anticonvulsants; Antipsychotic Agents; Carbamazepine; Child, Preschool; Chlorpromazine; Drug Therapy, Combination; Electroencephalography; Female; Humans; Landau-Kleffner Syndrome; Nigeria | 2002 |
Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Brain; Carbamazepine; Chlorpromazine; Diazepam; Fluvoxamine; Gene Expression; Haloperidol; Isoxazoles; Lithium; Male; Maprotiline; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Zonisamide | 2002 |
The study of growth inhibitive protein factor by various mode of HPLC and estimation of its binding with drugs.
Topics: Animals; Brain Chemistry; Carbamazepine; Chlorpromazine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Growth Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Nerve Tissue Proteins; Phenobarbital; Protein Binding; Rats; Serum Albumin; Spectrophotometry, Ultraviolet | 2005 |
Downregulation of the reduced folate carrier transport activity by phenobarbital-type cytochrome P450 inducers and protein kinase C activators.
Topics: Animals; Carbamazepine; Carrier Proteins; Cell Line, Tumor; Chlorpromazine; Clotrimazole; Cytochrome P-450 Enzyme System; DNA Primers; Down-Regulation; Enzyme Activators; Folate Receptors, GPI-Anchored; Immunohistochemistry; Okadaic Acid; Protein Kinase C; Rats; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Risk of death associated with antipsychotic drug dispensing in residential aged care facilities.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Comorbidity; Cross-Sectional Studies; Death, Sudden; Female; Haloperidol; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Risk; Valproic Acid; Veterans | 2007 |
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Cohort Studies; Dementia; Female; Haloperidol; Humans; Male; Mortality; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors; Survival Rate; Valproic Acid; Veterans; Widowhood | 2007 |
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Topics: Animals; Biomarkers; Carbamazepine; Chemical and Drug Induced Liver Injury; Chlorpromazine; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Enalapril; Gene Expression; Liver; Male; Oligonucleotide Array Sequence Analysis; Proteomics; Pyrazinamide; Ranitidine; Rats; Rats, Sprague-Dawley; Transcriptome | 2015 |
Inhibition effects of isoproterenol, chlorpromazine, carbamazepine, tamoxifen drugs on glutathione S-transferase, cholinesterases enzymes and molecular docking studies.
Topics: Acetylcholinesterase; Carbamazepine; Chlorpromazine; Cholinesterase Inhibitors; Glutathione Transferase; Isoproterenol; Molecular Docking Simulation; Pharmaceutical Preparations; Tamoxifen | 2021 |